thermosafe cts infographic r1 email · thermosafe cts infographic r1 email created date: 3/2/2017...

2
TECHNOLOGY INNOVATION SUPPLY CHAIN LOGISTICS ASSESSING THE CURRENT AND FUTURE STATE OF CLINICAL TRIAL SUPPLIES RESPONDENTS In order to gain a deeper understanding of this rapidly evolving Clinical Trial Supply market, Sonoco ThermoSafe, Berlinger & Co. AG and Arena International Events Group conducted a comprehensive and forward looking survey across global regions. The survey was developed and reviewed by an advisory panel of industry experts from clinical operations, clinical trial supply logistics and packaging, as well as bio-pharma manufacturing and supply chain organizations. Surveys were conducted at all Arena International events in 2016. ADVISORY PANEL Global Category Leader Freight & Logistics AstraZeneca SVP, Strategic Development Clinical Supplies Management Executive Director, Supply Chain FibroGen Director, Clinical Interface Group GlaxoSmithKline Clinical Logistics Leader OPKO Biologics Executive Director US Clinical Services PCI Clinical Services Global Operations Director, QuickStat Global Life Science Logistics Director of Operational Excellence Sunovion Pharmaceuticals NORTH AMERICA 76% EUROPE 12% 11% ASIA 2% REST OF THE WORLD PHARMA/BIOPHARMA 55% PACKAGING & LOGISTICS 17% OTHER 14% (inc. DRUG SOURCING, CRO, MEDTECH) 8% CMO/VIRTUAL MANUFACTURERS 6% CLINICAL SUPPORT/ TECHNOLOGY RESPONDENTS BY REGION RESPONDENT COMPANY SIZE RESPONDENTS BY INDUSTRY COMPANY ANNUAL REVENUE $ UP TO $50M 28% 12% 11% 24% 26% $50M- 250M 250M- $1BN $1BN- $10BN $10BN+ Download detailed survey report at www.thermosafe.com/ctssurvey TEMPERATURE CONTROLLED PACKAGING www.arena-international.com www.berlinger.com www.thermosafe.com

Upload: others

Post on 27-May-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ThermoSafe CTS InfoGraphic R1 email · ThermoSafe CTS InfoGraphic R1 email Created Date: 3/2/2017 6:24:53 PM

TECHNOLOGY INNOVATIONSUPPLY CHAINLOGISTICS

ASSESSING THE CURRENT AND FUTURESTATE OF CLINICAL TRIAL SUPPLIES

RESPONDENTS

In order to gain a deeper understanding of this rapidly evolving Clinical Trial Supply market, Sonoco ThermoSafe, Berlinger & Co. AG and Arena International Events Group conducted a comprehensive and forward looking survey across global regions. The survey was developed and reviewed by an advisory panel of industry experts from clinical operations, clinical trial supply logistics and packaging, as well as bio-pharma manufacturing and supply chain organizations. Surveys were conducted at all Arena International events in 2016.

ADVISORY PANEL

Global Category Leader Freight & LogisticsAstraZeneca

SVP, Strategic DevelopmentClinical Supplies Management

Executive Director, Supply ChainFibroGen

Director, Clinical Interface GroupGlaxoSmithKline

Clinical Logistics LeaderOPKO Biologics

Executive Director US Clinical ServicesPCI Clinical Services

Global Operations Director, QuickStat Global Life Science Logistics

Director of Operational ExcellenceSunovion Pharmaceuticals

NORTH AMERICA 76%

EUROPE 12%

11% ASIA

2% REST OF THE WORLD

PHARMA/BIOPHARMA 55%

PACKAGING & LOGISTICS 17%

OTHER 14%(inc. DRUG SOURCING, CRO, MEDTECH)

8% CMO/VIRTUAL MANUFACTURERS

6% CLINICAL SUPPORT/ TECHNOLOGY

RESPONDENTS BY REGION

RESPONDENT COMPANY SIZE

RESPONDENTS BY INDUSTRY

COMPANY ANNUAL REVENUE $

UP TO$50M

28% 12% 11% 24% 26%

$50M-250M

250M-$1BN

$1BN-$10BN

$10BN+

Download detailed survey report atwww.thermosafe.com/ctssurvey

TEMPERATURE CONTROLLED PACKAGING

www.arena-international.com

www.berlinger.com

www.thermosafe.com

Page 2: ThermoSafe CTS InfoGraphic R1 email · ThermoSafe CTS InfoGraphic R1 email Created Date: 3/2/2017 6:24:53 PM

14%

38%

LOGISTICS

DIRECT-TO-PATIENT DISTRIBUTION

TECHNOLOGY

SUPPLY CHAIN

INNOVATION

RAW MATERIAL toDRUG SUBSTANCE

DRUG SUBSTANCEto DRUG PRODUCT

DRUG PRODUCT toPRIMARY PACKAGING

PRIMARY PACKAGINGto FINISHED GOODS

55%

45%

59%

41%

68%

32%

71%

29%

DISTRIBUTION PATH/DRUG SUPPLY STAGE

LOGISTICS METHOD UTILIZED BY DISTRIBUTION PATH/DRUG SUPPLY STAGE

OUTSOURCED IN-HOUSE

S AMERICA

10%22%

68%

C AMERICA

14%

34%

52%

ASIA

22%

35%

42%

E EUROPE

33%

31%

36%

W EUROPE

55%

33%

11%N AMERICA

72%

20%8%

LOGISTICS CHALLENGE BETWEEN DEPOT TO CLINICAL SITES BY REGION

5 - CHALLENGING

3 - MODERATE

1- EASY

AREAS OF CONCERN ASSOCIATED WITH IMPORT BROKERS

COSTS

16%

32%

52%

VISIBILITY

22%

26%

53%

BRIBERY/CORRUPTION

43%

24%

30%

5 - VERY CONCERNED

3 - CONCERNED

1- NOT CONCERNED

32% COURIER

28% CRO

22% DEPOT

14% INTERNALLY MANAGED

4% OTHER

TYPE OF IMPORT BROKER USED

USE OF DTP SHIPMENTS FROM ADEPOT/CLINICAL SITE TO PATIENTS HOME

% LIKELIHOOD OF USING DTP IN FUTURE(NEXT 12 -18 MONTHS)

% REASONS FOR SHIPPING DTP % RISKS OF SHIPPING DTP

24% YES

76% NO

5VERY

LIKELYNOT

LIKELY

4%

4

6%

3

23%

2

5%

1

60%

IMPROVE PATIENTRETENTION BY

INCREASINGCONVENIENCE

PATIENT POOL SO WIDELYDISPERSED THAT

STANDARD POOLINGOPTIONS DO NOT APPLY

IMPROVECOMMUNICATION

DIRECTLY WITHPATIENTS

REDUCE CLINICALSUPPLY COSTS

OTHER 13%

17%

19%

LOSS OF COLDCHAIN CONTROL

PATIENT ADHERENCE TOCLOSE REQUIREMENTS

EMERGENCYREPLENISHMENT DUE

TO MISHANDLING OFINVESTIGATIONAL MATERIALS

LOST MATERIALS THROUGHSHIPPING MISTAKES

OTHER

28%

25%

23%

18%

6%

SUPPLY CHAIN TECHNOLOGIES USED

INTERACTIVERESPONSE

SYSTEM

MICROSOFTOFFICETOOLS

VENDORINVENTORY/

DISTRIBUTIONSYSTEM

TEMPERATUREMONITORINGDATABASE

CENTRALINVENTORY/

DISTRIBUTIONSYSTEM

FORECASTINGSYSTEM FOR

FINISHEDGOODS

OTHER(MISC DBASE/

MANUFACTURINGSYSTEM)

25% 24% 13% 13% 10% 8% 7%

PLANS TO EXPAND USE OFMOBILE TECHNOLOGY IN NEXT 1-2 YEARS

LEVEL OF MOBILE TECHNOLOGY USE AT WORK(EXCLUDES EMAIL & VOICE CALLS)

% OF RESPONDENTS

USE OF MOBILE TECHNOLOGY (EXC. EMAIL/CALLS)

31% NO

69% YES

Used<10%

55%

10%-25%

17%

26%-50%

12%

51%-75%

7%

76%+

9%

4% 16% 42% 32% 3% 4%

100%REACTIVE

100%PROACTIVE

50% REACTIVE,50% PROACTIVE

80% REACTIVE,20% PROACTIVE

80% PROACTIVE,20% REACTIVE OTHER

DEGREE OF IMPACT TOOLS HAVE ON SUCCESSFUL FORECASTING OF CLINICAL TRIAL SUPPLIES

RELIABLECRO WITH

GOODCOLLABORATION

87%

6%8%

RELIABLEDISTRIBUTER& PACKAGING

VENDOR

85%

RELIABLEMANUFACTURING

PRODUCTION

20%

DYNAMICIRT

SYSTEM

15%

OTHER

33%

TRIALCOMPLEXITY/

SIZE OFPATIENT POOL

5%EXCEL

SPREADSHEET

13%

SIMULATIONSOFTWARE

30%10%5% 6%

74% 69% 67% 65% 61% 47%

17% 31%25%

23%

MORE HELPFUL HELPFUL LESS HELPFUL

LEVEL OF INNOVATION

HOW INNOVATIVE IS YOUR ORGANIZATION?

3% - 1 (NOT INNOVATIVE)

10% - 2

39% - 3 (INNOVATIVE)

26% - 4

22% - 5 (VERY INNOVATIVE)

MAIN BARRIERS TO DRIVING INNOVATION AT YOUR ORGANIZATION

COST

25%

TIME

18%

PEOPLE

18%

RISKAVOIDANCE

& PASTFAILURES

15%

REGULATORYCONCERNS

9%

TOOLS

7%

CHANGECONTROL

DOCUMENTATION/PROCESSUPDATE

7%

NOBARRIERS

TOINNOVATION

2%